Biologic DMARD may be insufficient to inhibit CCL20 pathway in rheumatoid arthritis

J Rheumatol. 2010 Nov;37(11):2430. doi: 10.3899/jrheum.100551.
No abstract available

Publication types

  • Comment
  • Letter

MeSH terms

  • Antibodies, Monoclonal / immunology
  • Antibodies, Monoclonal / therapeutic use*
  • Antirheumatic Agents / immunology
  • Antirheumatic Agents / therapeutic use
  • Arthritis, Rheumatoid / immunology
  • Arthritis, Rheumatoid / therapy*
  • Chemokine CCL20 / immunology*
  • Humans

Substances

  • Antibodies, Monoclonal
  • Antirheumatic Agents
  • Chemokine CCL20